Sanofi SA reports results for the quarter ended September 30 - Earnings Summary

• Sanofi SA reported quarterly adjusted earnings of $2.04​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $1.70. The mean expectation of two analysts for the quarter was for earnings of $1.51 per share. Wall Street expected results to range from $1.49 to $1.53 per share.

• Revenue rose 14.4% to $16.61 billion from a year ago; analysts expected $15.28 billion.

• Sanofi SA's reported EPS for the quarter was $1.45​.

• Sanofi SA shares had risen by 4.6% this quarter and lost 11.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Sanofi SA is $55.75, about 22.6% above its last closing price of $43.13

This summary was machine generated from LSEG data October 30 at 11:29 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)